Impact of Neoadjuvant Therapy on Breast Conservation Rates in Triple- Negative and HER2-positive breast cancer: Combined results of CALGB 40603 and 40601 (Alliance)
      Google Scholar   
Citation:
J Clin Oncol vol 33 (suppl) abstr 1007
Meeting Instance:
ASCO 2015
Year:
2015
Type:
Abstract
Sub type:
Oral
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Meta-Analysis
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pub
Note:
This research was also supported, in part, by the Breast Cancer Research Foundation and Genentech
Methodological:
No
Biospecimen:
No
SDC:
No
Parents:
None
Children:
2342   2427  
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882, CA31946, CA076001  
Corr. Author:
 
Authors:
                       
Networks:
CA043, LAPS-CT018, LAPS-NC007, LAPS-NY016, LAPS-UT003, NY021, RI005   
Study
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-40601, CALGB-40603
Phases:
2, 3
Keywords: